SynthesisJournal of Korean medical science2014
Papillary thyroid microcarcinomas are different from latent papillary thyroid carcinomas at autopsy.
Synthesis in Journal of Korean medical science, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
27 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Risk factors associated with aggressive tumor phenotypes in papillary thyroid microcarcinoma: a systematic review and meta-analysis.Frontiers in endocrinology · 2026Pooled it
- Development and validation of a multivariable prediction model for lateral lymph node metastasis in papillary thyroid carcinoma.Gland surgery · 2026Article
- Clinical Impact of Multifocality and Bilaterality on Lymph Node Metastasis in Papillary Thyroid Microcarcinoma.Diagnostics (Basel, Switzerland) · 2026Article
- Papillary thyroid carcinoma measuring 1.0 cm or less: an epidemiological and clinicopathological study.Frontiers in oncology · 2025Article
- Thirty years of active surveillance for low-risk thyroid cancer, lessons learned and future directions.Reviews in endocrine & metabolic disorders · 2024Review
- Trends in incidence and overdiagnosis of thyroid cancer in China, Japan, and South Korea.Cancer science · 2023Article
- Papillary thyroid carcinoma within a mature cystic ovarian teratoma.Wiener medizinische Wochenschrift (1946) · 2023Article
- Conservative management of low-risk papillary thyroid carcinoma: a review of the active surveillance experience.Thyroid research · 2023Review
- The 2017 United States Preventive Services Task Force Recommendation for Thyroid Cancer Screening Is No Longer the Gold Standard.Endocrinology and metabolism (Seoul, Korea) · 2023Article
- Risk-stratified papillary thyroid microcarcinoma: post-operative management and treatment outcome in a single center.Endocrine · 2022Article
- Cytomorphological study of thyroid carcinoma.Experimental and therapeutic medicine · 2022Article
- The Application Value of the Central Lymph Node Metastasis Risk Assessment Model in Papillary Thyroid Microcarcinoma of Stage cN0: A Study of 828 Patients.Frontiers in endocrinology · 2022Article
- Active surveillance of highly suspicious thyroid nodules cohort in China shows a worse psychological status in younger patients.Frontiers in oncology · 2022Article
- Incidence of thyroid carcinomas in an extended retrospective study of 526 autopsies.Experimental and therapeutic medicine · 2021Article
- Secular Trends in Ablation Therapy for Graves' Disease: An Analysis of a 15-Year Experience at a Tertiary Hospital in South Korea.Journal of clinical medicine · 2021Article
- The Overdiagnosis of Thyroid Micropapillary Carcinoma: The Rising Incidence, Inert Biological Behavior, and Countermeasures.Journal of oncology · 2021Review
- Active surveillance in low risk papillary thyroid carcinoma.World journal of clinical oncology · 2020Review
- Genomic and Transcriptomic Characteristics According to Size of Papillary Thyroid Microcarcinoma.Cancers · 2020Article
- Early Diagnosis of Low-Risk Papillary Thyroid Cancer Results Rather in Overtreatment Than a Better Survival.Frontiers in endocrinology · 2020Review
- Sulfasalazine suppresses thyroid cancer cell proliferation and metastasis through T-cell originated protein kinase.Oncology letters · 2019Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The aim of this study was to review the literature of latent papillary thyroid carcinomas (PTCs) discovered at autopsy and describe the available pathologic and demographic differences from a group of papillary thyroid microcarcinomas (PTMCs) the reported in a previous publication. We searched the PubMed for published articles describing latent thyroid carcinomas detected at autopsy. Meta-analysis was performed to identify differences between the clinicopathologic features of PTMCs analyzed previously in our institution (Group I) and those of latent PTCs described in autopsy studies (Group II). We identified 1,355 patients with PTMC (Group I) and 989 with latent PTCs (Group II). Mean patient age was 47.3 yr in Group I and 64.5 yr in Group II. The male:female ratio was 1:10.9 in Group I and 1:1 in Group II. Most PTMCs (67.6%) were larger than 0.5 cm in size, whereas most latent PTCs were <1-3 mm in diameter. The rates of multifocality were 24.7% in Group I and 30.5% in Group II, and the rates of cervical lymph node metastasis were 33.4% in Group I and 10.0% in Group II. Currently available data indicated that clinically evident PTMCs differ from latent PTCs detected at autopsy. Therefore, these two entities should be regarded as different.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.